Ex Vivo Properties of Plasma Clot Formation and Lysis in Patients With Cancer at Risk for Venous Thromboembolism, Arterial Thrombosis, and Death

Translational Research - Netherlands
doi 10.1016/j.trsl.2019.08.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Risk of Cancer in Patients With Thyroid Disease and Venous Thromboembolism

Clinical Epidemiology
Epidemiology
2018English

Quantitation of Venous Clot Lysis With D-Dimer Assay During Catheter-Directed Thrombolysis for Lower Extremity Deep Venous Thrombosis

International Surgery
Surgery
2016English

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Treating Venous Thromboembolism in Patients With Cancer

Expert Review of Hematology
Hematology
2012English

Choriocarcinoma With Arterial and Venous Thrombosis

Neurology India
Neurology
2009English

Altered Fibrin Clot Structure/Function in Patients With Idiopathic Venous Thromboembolism and in Their Relatives

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Therapeutic Advances in Hematology
Hematology
2011English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2012English

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy